Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology | Hematology
Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
A Phase 1 Protocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multipe Myeloma
A Phase II Multicenter Study of CNTO 328 (Anti-IL-6 Monoclonal Antibody) in Subjects with Relapsed or Refractory Multiple Myeloma
An Open Label, Single Arm, Phase 2 Study of Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma
CALGB 100104/ECOG 100104: A Phase III Randomized, Double-Blind Study of Maintenance Therapy with CC-5013 (NSC #703813, IND #70116) or Placebo Following Autologous Stem Cell Transplantation for Multiple Myeloma
CIBMTR: 07-REV; Evaluation of Lenalidomide as Maintenance Therapy Post Allogenic Hematopoietic Cell Transplantation for High Risk Multiple Myeloma
Correlating Organ Dose and Dose-Volume with Toxicities After Total Marrow Irradiation (TMI) Using Helical Tomotherapy in Patients with Multiple Myeloma Undergoing Hematopoetic Cell Transplantation (HCT)
Multiple Myeloma Research Consortium Inc. Ancillary Tissue Collection Study
Phase I/II Study of VELCADE (Bortezomib), Dexamethasone, and Revlimid (Lenalidomide) (VDR) versus VELCADE, Dexamethasone, Cyclophosphamide, and Revlimid (VDCR) in Subjects with Previously Untreated Multiple Myeloma
Tandem High-Dose Therapy with Melphalan and Total Marrow Irradiation (TMI) with Peripheral Blood Progenitor Cell Support and Dexamethasone and Thalidomide Maintenance in Multiple Myeloma: A Phase I/II Trial
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
Multiple Myeloma Study CLBH589B2206
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
Safety, Efficacy, Dose-Finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
Multiple Myeloma Study CLBH589B2207
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
Multiple Myeloma Study CLBH589B2207
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Relapsed or Refractory Multiple Myeloma - Adults
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
VELCADE in subjects with Untreated Mutiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Double-Blinded Placebo Controlled Phase III Trial Comparing Dexamethasone (DEX) to the Combination of DEX + CC-5013 in Patients with Newly Diagnosed Multiple Myeloma.
Myeloma Specimen Repository Protocol, Ancillary.
Phase I/II Study of Liposomal Doxorubicin (Doxil®)/ Melphalan/ Bortezomib (Velcade®) in Relapsed/Refractory Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
Multiple Myeloma Study CLBH589B2206
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Phase II Study Of Antineoplatons A10 And AS2-1 In Patients With Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Division of Hematology/Oncology seeks adults over the age of 18 with first relapse of Multiple Myeloma.
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma
A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
